βIII-Tubulin: biomarker of taxane resistance or drug target?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

βIII-Tubulin: biomarker of taxane resistance or drug target?

Published:2013-02-02 Issue:4 Volume:17 Page:461-472
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Karki Roshan,Mariani Marisa,Andreoli Mirko,He Shiquan,Scambia Giovanni,Shahabi Shohreh,Ferlini Cristiano

Publisher

Informa Healthcare

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14728222.2013.766170

Reference84 articles.

1. Tubulins as Therapeutic Targets in Cancer: from Bench to Bedside

2. Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?

3. Is class III β-tubulin a predictive factor in patients receiving tubulin-binding agents?

4. Tubulin proteomics: Towards breaking the code

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cytotoxic natural compound erianin binds to colchicine site of β-tubulin and overcomes taxane resistance;Bioorganic Chemistry;2024-09

2. Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site;European Journal of Medicinal Chemistry;2024-03

3. Targeting Heme Oxygenase 2 (HO2) with TiNIR, a Theragnostic Approach for Managing Metastatic Non-Small Cell Lung Cancer;Biomaterials Research;2024-01

4. Sox2 and βIII-Tubulin as Biomarkers of Drug Resistance in Poorly Differentiated Sinonasal Carcinomas;Journal of Personalized Medicine;2023-10-18

5. Cytotoxicity of poly-guanidine in medulloblastoma cell lines;Investigational New Drugs;2023-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3